Improving Vaccine Delivery to the Developing World | Current delivery of liquid injectable vaccines to the developing world is currently based on the multi-dose vial. Investigations have shown that the cost per delivered dose with multi-dose vials is significantly higher than the initial cost per dose at the factory; wastage through loss of unused doses, glass breakage product loss and temperature excursions all add to the final cost per dose. Blow/Fill/Seal (BFS) advanced aseptic technology has been investigated for the application of single dose vaccine packaging. Ongoing work has shown that the technology is viable for producing single dose primary packaging for Live Attenuated and inactive vaccines. The work includes container and device designs for oral and injectable vaccines, product stability studies, cost comparison between packing technologies, and developing world human factor studies to test the container design and function. This presentation will introduce participants to BFS technology and its application to cold chain products, single dose container designs for oral and injectable vaccines, and the challenges around filling adjuvants.
General Manager-North America,